Faculty

Andrea Burnett-Hartman

Affiliate Instructor, Epidemiology


andrea.n.burnett-hartman@kp.org

Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Michigan, 2002
BPH Microbiology & Ecology, Miami University (Ohio), 2000

Contact


andrea.n.burnett-hartman@kp.org

Kaiser Permanente
Seattle, WA
View Website »

Research Interests

Dr. Burnett-Hartman's research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is also a co-investigator at the coordinating center for the NIH-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Colorectal Working Group and a KL2 Scholar at the University of Washington's Institute of Translational Health Sciences (ITHS). In collaboration with the ITHS biomedical informatics and research coordinator cores, Dr. Burnett-Hartman is working to develop, and test, protocols for using biomedical informatics to extract data from electronic medical records.

Recent Publications (PubMed)

Percentage Up to Date With Chest Computed Tomography Among Those Eligible for Lung Cancer Screening.
(2023 Jan 25)
Am J Prev Med
Burnett-Hartman AN, Carroll NM, Croswell JM, Greenlee RT, Honda SA, Neslund-Dudas CM, Kim RY, Rendle KA, Vachani A, Ritzwoller DP

Demographic, Clinical, and Behavioral Factors Associated With Electronic Nicotine Delivery Systems Use in a Large Cohort in the United States.
(2023)
Tob Use Insights 16(): 1179173X221134855
Goldberg Scott S, Feigelson HS, Powers JD, Clennin MN, Lyons JA, Gray MT, Vachani A, Burnett-Hartman AN

Validation of a genetic-enhanced risk prediction model for colorectal cancer in a large community-based cohort.
(2023 Jan 9)
Cancer Epidemiol Biomarkers Prev
Su YR, Sakoda LC, Jeon J, Thomas M, Lin Y, Schneider JL, Udaltsova N, Lee JK, Lansdorp-Vogelaar I, Peterse EFP, Zauber AG, Zheng J, Zheng Y, Hauser E, Baron JA, Barry EL, Bishop DT, Brenner H, Buchanan DD, Burnett-Hartman A, Campbell PT, Casey G, CastellvĂ­-Bel S, Chan AT, Chang-Claude J, Figueiredo JC, Gallinger SJ, Giles GG, Gruber SB, Gsur A, Gunter MJ, Hampe J, Hampel H, Harrison TA, Hoffmeister M, Hua X, Huyghe JR, Jenkins MA, Keku TO, Le Marchand L, Li L, Lindblom A, Moreno V, Newcomb PA, Pharoah PDP, Platz EA, Potter JD, Qu C, Rennert G, Schoen RE, Slattery ML, Song M, van Duijnhoven FJB, Van Guelpen B, Vodicka P, Wolk A, Woods MO, Wu AH, Hayes RB, Peters U, Corley DA, Hsu L

Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence.
(2022 Oct 28)
Am J Respir Crit Care Med
Kim RY, Rendle KA, Mitra N, Saia CA, Neslund-Dudas C, Greenlee RT, Burnett-Hartman AN, Honda SA, Simoff MJ, Schapira MM, Croswell JM, Meza R, Ritzwoller DP, Vachani A

Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines.
(2022 Nov)
Ann Intern Med 175(11): 1582-1590
Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Elston Lafata J, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN

Show complete publication list

In the News

No news articles at this time.